AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
TRS

TriMas Corporation Common Stock (TRS) fair value

Consumer Cyclical · Packaging & Containers · NASDAQ · United States
$39.60-0.75%
Market cap $1.4BNext earnings 2026-10-29Updated Oct 19, 2026
Add earnings to calendarGoogle
Our verdict
Trades 93% above our fair value
Price
$39.60
Model fair valueConfidence: medium
$20.57
Only one of our models could value this stock with confidence, so use it as a guide.
Not used by alerts or posts.
Valued as a cyclical company: P/E comparison.
ACCE opinionTriMas Corporation Common Stock (TRS)
Fair value (3 models)
Not available
ACCE price target
$38.00
Rating
Not rated
Horizon
12 months
ACCE price target published on 12 Oct 2026, 00:00 CEST.
Price used: $39.60 at the close on 23 Oct 2026, 22:00 CEST.
Models: P/E comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
55
out of 100
Analysts
100% buy
2 covering
P/E
16.2x
forward 19.3x
1-year return
+0.4%
Dividend yield
0.40%

TriMas Corporation Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

TriMas makes specialty packaging, including closures, dispensing systems and steel and plastic containers sold largely into consumer end markets, plus a smaller Aerospace business. Its edge is in engineered, customer-qualified components that are costly to switch, but the ceiling is visible in the numbers: revenue growth of 1.6%, a 21.3% gross margin and a 7.4% operating margin leave little room for error. The main lever to watch is margin recovery in the packaging segments and any cost or portfolio action that lifts returns, since ROE of 7.7% is thin for a manufacturer of this size. At a P/E of 15.6 and a forward P/E of 19.3, the market is pricing in earnings growth that the top line is not yet showing, which is the gap a deeper look needs to resolve. The score of 50/100 and absence from major indices suggest the name is under-followed, so the question is whether the margin trajectory justifies the forward multiple.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
  • high
    Revenue and earnings shrinking
    Revenue grew only 1.6% YoY, earnings fell 9.7%, and 5-year revenue CAGR is -3.5%. QoQ revenue dropped 34.4%, a sharp near-term slide.
  • moderate
    Score down sharply in 90 days
    ACCE score fell 14 points from 67 to 53 over 90 days, with growth at 19/100 and quality at 57/100.
  • moderate
    Heavy short interest
    Short interest stands at 16.1%, which signals meaningful bearish positioning against the stock.

AI research notes

AI-assisted·How I use AIWritten Oct 19, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Free cash flow over the last twelve months reached $69M, a solid cash base for a company of this size.
  • Latest quarterly earnings per share beat expectations, coming in at 0.52 against 0.49 expected, a 6.1% surprise.
Why it could disappoint
  • The reported 136.3% net margin is inflated by a one-off gain, so it should not be read as a sign of underlying profitability.
  • Revenue has shrunk by an average of 3.5% a year over five years, and the latest year's 1.6% growth does not yet reverse that trend.
  • At 18.2x forward earnings the stock trades above the sector median of 17.6x, while return on equity of 7.7% is modest.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Oct 29, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where TRS's valuation models land
Price
$39.60
Model fair valueConfidence: medium
$20.57
Model
Fair value
Upside
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bullish100% buy · 2 covering analysts
● Strong buy 1● Buy 1● Hold 0● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
+2.2%
1 month
+1.0%
3 months
-1.1%
6 months
+7.3%
YTD
+11.7%
1 year
+0.4%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
12 Oct 2026, 00:00 CESTACCE price target$38.00first publication$38.15
18 Aug 2026, 00:00 CESTFair value$30.87$31.25$38.83
12 Aug 2026, 00:00 CESTFair value$31.25$31.58$39.83
3 Jul 2026, 00:00 CESTFair value$31.58$32.00$41.73
1 Jul 2026, 00:00 CESTFair value$32.00first publication$45.03

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full TRS page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth19Value74Quality57Momentum70Total55
Valuation
Trailing P/E
16.2x
Forward P/E
19.3x
PEG
no data
P/B
0.97x
EV / Revenue
0.9x
Book value/sh
$40.22
Enterprise value
$602M
Profitability
ROE
7.7%
FCF yield
4.83%
ROIC
8.1%
Health and risk
Debt / equity
0.72
Dividend yield
0.40%
Beta
0.61

Price

-0.9% · 1Y

Ask anything about TRS

Answered from TriMas Corporation Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 50% of peers
low 0.0x16.2xhigh 45.4x
ROEbetter than 50% of peers
low -118%8%high 31%
Div yieldbetter than 33% of peers
low 0.0%0.4%high 5.9%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
TRS TriMas Corporation Common Stock$39.60--16.2x7.7%5755
ORA.AX Orora LimitedA$1.53A$27% below--25.5%4042
MYE Myers Industries Inc. Common Stock$32.13$2154% above23.8x17.2%6077
WPK.TO Winpak Ltd.C$43.58C$5013% below13.7x10.2%6664
KRT Karat Packaging Inc. Common Stock$53.00$576% below21.2x30.6%7473
OI O-I Glass Inc. Common Stock$6.47----118.3%1834
VRLA.PA Verallia Société Anonyme€18.60--45.4x5.4%3840

Sector report card

Where TRS ranks against its sector peers on each metric.

Computing percentiles…
  • Business Wire•Oct 5, 2026
    TriMas Announces Third Quarter 2026 Earnings Conference Call Date
  • Business Wire•Sep 14, 2026
    TriMas Packaging to Showcase Global Beauty Packaging Capabilities at Leading Trade Shows This Fall
  • Business Wire•Aug 4, 2026
    TriMas Publishes 2025 Sustainability Report
3 more press releases · full archive on Investor+.INVESTOR
37 filings
October 2026
Oct 14
Form 4Insider transactionPeriod 2026-10-13
View on SEC →
August 2026
Aug 14
Form 4Insider transactionPeriod 2026-08-12
View on SEC →
July 2026
Jul 31
10-QQuarterly reportPeriod 2026-06-30
View on SEC →
34 more filings + AI summaries on Investor+.INVESTOR